Abstract
Objective
To evaluate the predicted mortality rate of oncologic patients in the PICU using the PRISM score and factors that might influence short-term outcomes.
Design
Retrospective study.Setting: Pedriatic ICU in a university hospital
Patients and Methods
The medical charts of all oncologic patients admitted to the PICU during the period from January 1983 to December 1992 were reviewed.
Main Results
Over a period of 10 years, 51 oncologic patients were admitted on 57 occasions to the PICU. The mortality was 32%. This is significantly higher than the overall mortality in the PICU (8%). Comparison of observed and predicted mortality, derived from the PRISM score, using chi square goodness-of-fit tests showed a significantly higher observed mortality (x 2(5)=20.1,P<0.01). Patients admitted for circulatory failure and the highest mortality (47%), followed by those with respiratory failure due to tachypnea/cyanosis (36%), central nervous system deterioration (27%), respiratory failure due to ariway obstruction (25%), and metabolic disorders (20%). Of the 31 patients who needed mechanical ventilation, 17 died (55%), and when they needed inotropic support as well, the mortality increased to 69%. The mortality rose to 100% when the patient was admitted with a septic shock, necessitating mechanical ventilation and inotropic support. The median PRISM score was 5 in the survivor group and 18.5 in the non-survivor group; this difference was found to be significant using the Wilcoxon test (P=0.01). However, some patients with high scores were found in the survivor group, as well as some with low scores in the non-survivor group.
Conclusion
The decision to treat opcologic patients in a PICU remains difficult and has to be considered on an individual basis. However, oncologic patients do benefit from admission to the PICU. The PRISM score is not suitable for oncologic patients in the PICU, because it underestimates the observed mortality. Other factors like neutropenia, septic shock, the need for mechanical ventilation, and inotropic support should be taken into consideration.
Similar content being viewed by others
References
Gloeckler Ries LA, Hankey BF, Miller BA (1991) Cancer Statistics Review 1973–1988 I. 16
Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16: 1110–1116
Sivan Y, Schwartz PH, Schonfeld T, Cohen IJ, Newth CJL (1991) Outcome of oncology patients in the pediatric intensive care unit. Intensive Care Med 17:11–15
Butt W, Barker G, Walker C, Gillis J, Kilham H, Stevens M (1988) Outcome of children with hematologic malignancy who are admitted to an intensive care unit. Crit Care Med 16:761–764
Heney D, Lewis IJ, Lockwood L, Cohen AT, Baily CC (1992) The intensive care unit in pediatric oncology. Arch Dis Child 67:294–298
Hinshaw L (1987): Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659–665
De Bruin W, Notterman DA, Magid M, Godwin T, Johnston S (1992) Acute hypoxemic respiratory failure in infants and children: clinical and phathologic characteristics. Crit Care Med 20:1223–1234
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Veen, A., Karstens, A., van der Hoek, A.C.J. et al. The prognosis of oncologic patients in the pediatric intensive care unit. Intensive Care Med 22, 237–241 (1996). https://doi.org/10.1007/BF01712243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01712243